Back to results
US 10,472,628 B2Granted
Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
AssigneeAlnylam Pharmaceuticals, Inc.
InventorsAntonin de Fougerolles, Tatiana Novobrantseva, Gregory Hinkle
Life of this patent
Estimating the term…
Abstract
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a Serum Amyloid A (SAA) gene, and methods of using the dsRNA to inhibit expression of SAA.
Claims18
A double-stranded ribonucleic acid (dsRNA), wherein said dsRNA comprises a sense strand consisting of the nucleotide sequence of SEQ ID NO:189 and an antisense strand consisting of the nucleotide sequence of SEQ ID NO:190.
Dependencies are inferred from the claim text.